iShares TIPS Bond ETF vs Tilray Brands Inc — how do they compare? iShares TIPS Bond ETF trades at $104.65 (market cap $14.17B), while Tilray Brands Inc trades at $3.61 (market cap $530.54M). The key difference: iShares TIPS Bond ETF is far larger — about 26.7× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 1,780,688). Which is the better fit depends on your goals — on Pluang, investors hold iShares TIPS Bond ETF for 61 Days and Tilray Brands Inc for 31 Days on average.
| TIP | TLRY | |
|---|---|---|
Market Cap | $14.17B | $530.54M |
Volume | 1,780,688 | 9,099,075 |
Sector | Fixed Income | Health |
52-Week High | $112.20 | $21.00 |
52-Week Low | $103.98 | $3.57 |
Typical Hold Time | 61 Days | 31 Days |
Enterprise Value | — | $684.46M |
Signals from Pluang's Aura AI — not financial advice
TIP trades at $104.24 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling caution while oscillators remain neutral. The ETF faces headwinds from rising bond yields and inflationary pressures affecting fixed income markets. Recent institutional activity shows Envestnet Asset Management increased its stake by 3.5% in the latest quarter.
The outlook remains challenging amid persistent bond market volatility and rising interest rates. Investment opportunity exists for inflation-protected exposure, though risks include continued yield increases and geopolitical tensions driving oil prices higher. Current technical weakness suggests cautious positioning may be warranted until market conditions stabilize.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →